Oramed Pharmaceuticals (ORMP) Cash Flow: Operating & Free Cash Flow

Oramed Pharmaceuticals Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Oramed Pharmaceuticals Inc. (ORMP) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012
Period ending	Dec 2025	Dec 2024	Dec 2023	Sep 2023	Dec 2022	Dec 2021	Aug 2021	Aug 2020	Aug 2019	Aug 2018	Aug 2017	Aug 2012
Operating Activities
Net Income	64.02	-19.10	5.09	5.53	-37.76	-12.26	-22.24	-11.51	-14.36	-12.73	-10.48	-3.34
Depreciation & Amortization	0.12	0.19	0.20	0.20	0.06	0.02	0.08	0.01	0.01	0.01	0.01	0.01
Deferred Income Tax	7.91	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	-
Stock Based Compensation	5.99	4.05	4.21	0.00	11.53	5.33	2.70	0.47	0.81	1.55	1.58	0.38
Change in Working Capital	-1.91	3.20	-2.70	-2.70	-0.94	-1.32	-1.32	-3.16	0.29	-3.60	2.87	-
Change in Accounts Payable	1.13	3.53	-2.23	-2.23	-0.38	0.69	2.06	-0.82	0.50	-0.61	1.26	0.20
Change in Other Working Capital	-3.04	-0.33	1.47	-0.47	0.14	-0.48	1.04	-2.34	-0.21	-2.99	1.62	0.06
Other Operating Activities	-85.28	3.25	1.47	-13.32	-0.80	0.04	1.04	1.76	0.31	0.12	0.20	0.39
Net Cash from Operating Activities	-9.15	-8.41	-10.30	-10.30	-27.92	-33.37	-21.18	-12.44	-12.94	-14.66	-5.83	-2.30
Investing Activities
Capital Expenditures	-1.93	-0.02	-0.25	-0.25	-0.50	-0.03	-0.38	-0.08	-0.01	0.00	-0.01	0.00
Acquisitions	-7.25	0.00	-	0.00	0.02	-	1.50	0.00	0.00	0.00	0.00	-
Purchases of Investments	-88.51	-55.76	-190.92	-190.92	-154.41	1.61	-53.82	-39.38	-26.35	-26.57	-24.66	-0.48
Sales/Maturities of Investments	96.88	161.66	118.14	118.14	185.09	0.76	30.43	44.09	41.86	19.57	28.97	2.25
Other Investing Activities	6.25	-0.07	-	0.00	0.00	-25.00	0.00	0.00	-4.24	0.00	0.00	0.00
Net Cash from Investing Activities	5.44	105.82	-73.04	-73.04	30.21	-297.74	-23.76	4.63	11.26	-7.00	4.30	1.77
Financing Activities
Debt Repayment	0.00	-49.55	-50.00	49.55	0.00	-	0.00	0.00	0.00	0.00	0.00	-
Common Stock Issued	0.00	0.00	2.43	2.43	11.56	60.57	79.98	23.79	0.00	22.65	1.59	3.49
Common Stock Repurchased	-4.74	-2.48	-	0.00	-0.78	-	0.00	0.00	0.00	0.00	0.00	-
Other Financing Activities	0.00	0.00	-	0.00	-0.78	1.50	1.50	0.00	0.00	0.00	0.00	-
Net Cash from Financing Activities	-4.74	-52.04	51.98	51.98	10.78	181.72	102.89	23.79	0.00	22.65	1.59	3.49
Summary
Effect of Forex Changes on Cash	-0.03	0.00	-0.05	-0.05	-0.06	-	0.00	0.00	0.01	0.02	0.01	-0.04
Net Change in Cash	-8.47	45.37	-31.41	-31.41	13.01	-149.37	57.95	15.97	-1.67	1.01	0.06	2.92
Cash at Beginning of Period	54.42	9.06	40.46	40.46	27.46	-	19.30	3.33	5.00	3.99	3.92	-
Cash at End of Period	45.95	54.42	9.06	9.06	40.46	-	77.25	19.30	3.33	5.00	3.99	-
Free Cash Flow	-11.08	-8.43	-10.55	-10.55	-28.41	-33.39	-21.56	-12.52	-12.96	-14.66	-5.84	-2.30
Supplemental Disclosures
Interest Paid	-	2.32	0.57	-	-	-	-	-	-	-	-	-
Income Taxes Paid	-	-	-	-	0.10	0.30	-	-	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Oramed Pharmaceuticals Cash Flow

What is Oramed Pharmaceuticals's free cash flow?

Oramed Pharmaceuticals had negative free cash flow of $11.08M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$9.14M minus $1.93M of capital expenditures.

How much does Oramed Pharmaceuticals spend on capital expenditures?

Oramed Pharmaceuticals spent $1.93M on capital expenditures in fiscal 2025, compared with $18.00K a year earlier.

Does Oramed Pharmaceuticals pay dividends or buy back shares?

Yes. In fiscal 2025 Oramed Pharmaceuticals returned $4.74M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition